acrolein has been researched along with Parkinsonian Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, HJ; Lin, AM; Lin, HC; Lo, YL; Wang, HT; Wang, YT; Zhao, WZ | 1 |
1 other study(ies) available for acrolein and Parkinsonian Disorders
| Article | Year |
|---|---|
Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death.
Topics: Acrolein; alpha-Synuclein; Animals; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Encephalitis; Male; Oxidative Stress; Parkinsonian Disorders; Protein Aggregation, Pathological; Rats, Sprague-Dawley; Substantia Nigra | 2017 |